Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 25281-25290 Newer>

The Motley Fool August 8, 2007 Anders Bylund	Cisco Steamrolls Another Year: Fool by Numbers Cisco management credits a truly long-term business plan for their full-year 2007 results. Year-over-year growth was 22%, for the 16th year in a row.
The Motley Fool August 8, 2007 Dave Mock	j2 Global Walks the Talk j2 Global is able to price products at a premium while keeping its customers. The internet communications and fax company has had 11 consecutive fiscal years of revenue growth, and five consecutive fiscal years of growing operating earnings.
The Motley Fool August 8, 2007 Brian Lawler	Array's Bright Pipeline Array BioPharma announces its goals for the months ahead in its fourth-quarter results. What is interesting is the varied mix of new compounds in their pipeline.
The Motley Fool August 8, 2007 Anders Bylund	Nuance Communications Speaks Up The market for Nuance Communications speech and character recognition software is exploding; listen up, because Nuance is the clear leader in this growing field.
The Motley Fool August 8, 2007 Rick Aristotle Munarriz	Beam Me Up, Priceline Wall Street is hanging out at the wrong gate again, and Priceline shareholders couldn't be happier.
The Motley Fool August 8, 2007 Lawrence Rothman	Heelys' Wheels Are Falling Off Heelys, the roller-shoe specialist, just completed a very good quarter, but shares are way, way down, on news of the end of the sneakers-with-removable-wheels fad.
The Motley Fool August 8, 2007 Toby Shute	Comstock Pumps Up Production The oil & gas player exceeds expectations, thanks in part to its offshore subsidiary. Investors, take note.
The Motley Fool August 8, 2007 Dave Mock	Expenses Up = Clearwire Down Investors cite more than 100 million reasons to sell wireless upstart Clearwire's stock. That would be the $118 million net loss, a sum that surprised even a few analysts.
The Motley Fool August 8, 2007 Brian Orelli	Inverness Does It Again Another month, another company to buy. Is Inverness Medical Innovations finally spreading itself too thin? The company just announced its seventh acquisition or joint venture in 18 months.
The Motley Fool August 8, 2007 Brian Orelli	Is Indevus Headed to the Black? Two new drugs should help turn things around at specialty pharmaceutical company Indevus. The company is not in the black yet, but they have been on a roll these last three months with FDA approvals of two new drugs.
<Older 25281-25290 Newer> Return to current articles.